Sincalide
- Generic Name
- Sincalide
- Brand Names
- Kinevac
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 25126-32-3
- Unique Ingredient Identifier
- M03GIQ7Z6P
- Background
Sincalide is a medication given by injection to assist in the diagnosis of gallbladder and pancreas disorders. It is identified as the 8-amino acid C-terminal segment of cholecystokinin and is also known as CCK-8. Naturally occurring cholecystokinin is a gastrointestinal peptide hormone normally essential for stimulating protein and fat digestion in the body...
- Indication
As the product Kinevac (FDA), sincalide is used for the following indications: 1) to stimulate gallbladder contraction, as may be assessed by various methods of diagnostic imaging, or to obtain by duodenal aspiration a sample of concentrated bile for analysis of cholesterol, bile salts, phospholipids, and crystals; (2) to stimulate pancreatic secretion in co...
- Associated Conditions
- -
- Associated Therapies
- X-ray imaging, Fluoroscopy, To stimulate gallbladder contraction, To stimulate pancreatic secretion therapy
Thyroid Hormones Homeostasis and Energy Metabolism Changes During Stimulation of Endogenously Secreted Bile Acids (BAs)
- Conditions
- Interventions
- First Posted Date
- 2008-06-27
- Last Posted Date
- 2020-07-22
- Target Recruit Count
- 31
- Registration Number
- NCT00706381
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Sincalide (Cholecystokinin Octapeptide) Versus Placebo in Neonates at High Risk for Developing Parenteral Nutrition Associated Cholestasis
- Conditions
- First Posted Date
- 1999-10-19
- Last Posted Date
- 2015-03-25
- Lead Sponsor
- University of Michigan
- Target Recruit Count
- 252
- Registration Number
- NCT00004414
- Locations
- 🇺🇸
University of Michigan Medical School, Ann Arbor, Michigan, United States
🇺🇸Baylor University Medical Center, Dallas, Texas, United States
🇺🇸University of Rochester Medical Center, Rochester, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.